[Adalimumab therapy for Vogt-Koyanagi-Harada syndrome].
Díaz Llopis
M
M
Amselem
L
L
Romero
F J
FJ
García-Delpech
S
S
Hernández
M L
ML
D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D013997:Time Factors; D016896:Treatment Outcome; D014607:Uveomeningoencephalitic Syndrome / Q000175:diagnosis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab